Results

Total Results: 429 records

Showing results for "cardiac".
Users also searched for: ekg

121. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
     April 02, 2015 - regular consumption of fish and seafood is associated with lower risk of coronary heart disease and cardiac … Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease … Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias … Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: … [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 65. exp arrhythmias, cardiac

122. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - This phenomenon, characterized by inadequate flow at the cardiac tissue level despite patent coronary … found that use of catheter aspiration, age, and symptom to balloon time were significant predictors of cardiac … Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention … Catheter in Infarct-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac … is strongly persistent at the end of the washout phase (i.e., dye is strongly persistent after three cardiac

123. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
     December 01, 2023 - , and 50 percent by comorbidities (including prepregnancy body mass index, diabetes, hypertension, cardiac

124. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart … Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable … Thus the question becomes, At what point following a cardiac revascularization procedure does a patient … trials included in Key Question 1, including HOPE, PEACE, and EUROPA (EURopean trial On reduction of cardiac … Thus the question becomes, At what point following a cardiac revascularization procedure does a patient

125. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
     April 15, 2021 - please clarify the sixth bullet “Lithium is more likely to be associated with overall congenital and cardiac … yet many clinicians are most likely to use valproic acid when they are fearful of congenital and cardiac … Furthermore, given the lengthy discussion of multiple studies in this section (with 7 studies on cardiac … The discussion of paroxetine and cardiac defects implies that the FDA categorization was incorrect. … We added a small note to indicate that the concern regarding cardiac malformation was at the time of

126. hemangioma-protocol-141223 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
     December 23, 2014 - congenital anomalies such as PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac … obstruction • Preservation of vision • Preservation of organ function (e.g., thyroid function, cardiac … obstruction § Preservation of vision § Preservation of organ function (e.g., thyroid function, cardiac … obstruction § Preservation of vision § Preservation of organ function (e.g., thyroid function, cardiac … imperforate anus, and skin tag PHACES: Posterior fossa malformations–hemangiomas–arterial anomalies–cardiac

127. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - complications (e.g., restenosis, stent thrombosis, and dissection) • Other measures (e.g., findings of cardiac … clinical status (e.g., death, acute MI, repeat revascularization, composite endpoint of major adverse cardiac … reports (83 articles); irrelevant comparators (e.g., intravascular diagnostic techniques compared with cardiac … 0.81 (0.65, 1.01) Long term 3 (587) 0.67 (0.50, 0.90)* 5 (7,700) 0.84 (0.57, 1.25) Major adverse cardiac … IVUS-guided stent placement and stent placement guided by angiography alone for all-cause mortality, cardiac

128. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
     January 01, 2011 - with diabetes often experience sev- eral associated medical complications, such as renal disease, cardiac … are of- ten categorized as microvascular (e.g., nephropathy, retinopathy) and macro- vascular (e.g., cardiac

129. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - haloperidol or second-generation antipsychotics used for the prevention or treatment of delirium, but cardiac … Evidence Summary > Adverse Effects: Consider opening this section with a short summary of adverse cardiac … more text in the discussion (particularly the executive summary) into the sub-populations studied (cardiac … One part of the document notes that post- operative patients had had hip surgery, GI surgery, and cardiac

130. Real World Effectiveness of Implantable Cardioverter Defibrillators (ICDs) in Medicare Patients | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/carioverter-difibrillators/abstract

131. S81 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
     October 01, 2007 - LOS) was �4 days and there was a complication; or if LOS was �4 days and the patient was a woman with cardiac … P-222) 0.21 7 28 94 0.61 7.1 5.32 0.0000 Length of stay �4 d† 0.21 69 90 31 0.60 2.2 3.83 0.0167 Cardiac … Cardiac dysrhythmias and lipid disor- ders—the latter being a surrogate for coronary artery dis- ease—are

132. Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
     February 01, 2010 - patient data on a set of core clinical variables consisting of demographics (age, sex, and ethnicity), cardiac … The synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) study … The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study

133. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
     December 01, 2010 - diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … agranulocytosis 2. seizures 3. myocarditis 4. cardiovascular and respiratory effects, (respiratory and/or cardiac

134. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
     February 01, 2013 - Associate Chief Division of Cardiothoracic Surgery Emory University School of Medicine Chief of Cardiac … clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac … “heart”[MeSH Terms] OR “heart”[All Fields] OR “coronary”[All Fields]) OR cardiovas*[All fields] OR cardiac … angina’:ab OR ‘cardiovascular diseases’:ti OR ‘heart diseases’:ti OR heart:ti OR cardiovasc*:ti OR cardiac … June 5, 2012 Set # Terms #1 cardiovascular diseases OR heart diseases OR heart OR cardiovas* OR cardiac

135. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
     July 01, 2014 - Child Harm Outcomes • Death, including suicide, all-cause mortality, and cause-specific death (e.g., cardiac … No comparative evidence on the risk of cardiac malformations in women treated for depression during … Results were similar for cardiac malformations, except that limiting our analyses to the highest quality … significantly associated with increased risk for major malformations (OR, 1.31; 95% CI, 1.04 to 1.65) and cardiac … First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis

136. Disseminating Findings From EPC Reports: Pilot Project of Three Products (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
     October 01, 2018 - • There was no difference between IOCM and LOCM for secondary outcomes, such as cardiac events, … contrast-induced nephropathy (CIN) • Secondary outcomes: patient characteristics (renal replacement therapy, cardiac

137. Covariate Selection for Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
     January 01, 2013 - cardiovascular disease risk, derived and summarized using the DRS, in a study of antipsychotics and sudden cardiac … Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001 Dec;58(12):1161-7.

138. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
     December 20, 2011 - could be used for diagnosis in acute and non-acute settings, its prognostic value for HF and other cardiac … was consistent evidence that BNP and NT-proBNP were independent predictors of mortality and other cardiac … 2005 4,14 have evaluated the evidence that BNP and NT-proBNP are predictive of mortality and other cardiac … How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure

139. Phenylketonuria Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
     February 01, 2012 - affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … measures of executive function • Prevention of neurologic impairment • Prevention of cardiac … These include studies on the cardiac effects of BH4.

140. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
     October 06, 2006 - Vol- Death* Dr Vol- CABG* Notes Primary Studies: National Kimmel S et al.248 Society for Cardiac … Clinical Databases: National Peterson E et al.210 Society of Thoracic Surgeons National Cardiac … Pts=patients; Hosp=hospital; vol=volume; Dr=physician; RA= Risk adjusted; AE= Adverse events; CSRS=cardiac … Clinical Databases CABG: National Peterson E et al.210 Society of Thoracic Surgeons National Cardiac … ischemia ο Other (Specify _______) Components of Primary Endpoint (N= ) ο Total Mortality ο Cardiac